Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anh Do

Showing results (301-310 of 379) with videos related to

Pageof 38
Sort By:
Molecular Cancer Therapeutics|December 7, 2018
Cooperative Effect of Oncogenic <i>MET</i> and <i>PIK3CA</i> in an HGF-Dominant Environment in Breast CancerShuying Liu, Shunqiang Li, Bailiang Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Multivariable model for time to first treatment in patients with chronic lymphocytic leukemiaWilliam G Wierda, Susan O'Brien, Xuemei Wang, et al.
Archives of Environmental Contamination and Toxicology|February 3, 2006
Geographical clustering of pancreatic cancers in the Northeast Nile Delta region of EgyptA S Soliman, X Wang, J-D Stanley, et al.
Leukemia|November 14, 2019
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromesGuillermo Montalban-Bravo, Caleb A Class, Irene Ganan-Gomez, et al.
Experimental Hematology|September 23, 2022
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaFaezeh Darbaniyan, Hong Zheng, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 31, 2021
Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Faezeh Darbaniyan, Rashmi Kanagal-Shamanna, et al.
Leukemia|June 13, 2022
Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemiaYue Wei, Rashmi Kanagal-Shamanna, Hong Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancerAna M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, et al.
Journal of the National Cancer Institute|April 5, 2017
Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung AdenocarcinomaMüge Çeliktas, Ichidai Tanaka, Satyendra Chandra Tripathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast CancerKelly K Hunt, Cansu Karakas, Min Jin Ha, et al.
Pageof 38

Showing results (301-310 of 379) with videos related to

Sort By:
Pageof 38
Molecular Cancer Therapeutics|December 7, 2018
Cooperative Effect of Oncogenic <i>MET</i> and <i>PIK3CA</i> in an HGF-Dominant Environment in Breast CancerShuying Liu, Shunqiang Li, Bailiang Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Multivariable model for time to first treatment in patients with chronic lymphocytic leukemiaWilliam G Wierda, Susan O'Brien, Xuemei Wang, et al.
Archives of Environmental Contamination and Toxicology|February 3, 2006
Geographical clustering of pancreatic cancers in the Northeast Nile Delta region of EgyptA S Soliman, X Wang, J-D Stanley, et al.
Leukemia|November 14, 2019
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromesGuillermo Montalban-Bravo, Caleb A Class, Irene Ganan-Gomez, et al.
Experimental Hematology|September 23, 2022
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaFaezeh Darbaniyan, Hong Zheng, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 31, 2021
Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Faezeh Darbaniyan, Rashmi Kanagal-Shamanna, et al.
Leukemia|June 13, 2022
Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemiaYue Wei, Rashmi Kanagal-Shamanna, Hong Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancerAna M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, et al.
Journal of the National Cancer Institute|April 5, 2017
Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung AdenocarcinomaMüge Çeliktas, Ichidai Tanaka, Satyendra Chandra Tripathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast CancerKelly K Hunt, Cansu Karakas, Min Jin Ha, et al.
Pageof 38